# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA4480297 | Binding | Inhibition of DOT1L (2 to 416 residues) (unknown origin) using biotinylated nucleosomes as substrate preincubated for 30 mins followed by substrate addition in presence of [3H-Me]SAM by scintillation proximity assay | Homo sapiens | 13 | ALA4477274 | single protein format | Scientific Literature | |
2. | ALA4480298 | Binding | Binding affinity to human Avi-tagged DOT1L (2 to 416 residues) assessed as target residence time by surface plasmon resonance assay | Homo sapiens | 2 | ALA4477274 | single protein format | Scientific Literature | |
3. | ALA4480299 | Binding | Inhibition of DOT1L in human HeLa cells assessed as reduction in H3K79me2 level after 72 hrs by ELISA | Homo sapiens | 2 | ALA4477274 | cell-based format | Scientific Literature | |
4. | ALA4480300 | Binding | Inhibition of DOT1L in human MOLM13 cells assessed as suppression of HoxA9 gene after 72 hrs by luciferase reporter gene assay | Homo sapiens | 2 | ALA4477274 | cell-based format | Scientific Literature | |
5. | ALA4480301 | Functional | Antiproliferative activity against human MV4-11 cells harboring MLL-AF4 treated for 6 hrs measured after 8 days by Celltiter-Glo reagent based assay | Homo sapiens | 2 | ALA4477274 | cell-based format | Scientific Literature | |
6. | ALA4480302 | ADME | Permeability of compound by HDM-PAMPA assay | 2 | ALA4477274 | assay format | Scientific Literature | ||
7. | ALA4480304 | ADME | Clearance in Sprague-Dawley rat at 1 mg/kg, iv administered as bolus dose measured up to 48 hrs by LC-MS/MS analysis | Rattus norvegicus | 1 | ALA4477274 | organism-based format | Scientific Literature | |
8. | ALA4480305 | ADME | Volume of distribution in Sprague-Dawley rat at 1 mg/kg, iv administered as bolus dose measured up to 48 hrs by LC-MS/MS analysis | Rattus norvegicus | 1 | ALA4477274 | organism-based format | Scientific Literature | |
9. | ALA4480306 | ADME | Half life in Sprague-Dawley rat at 1 mg/kg, iv administered as bolus dose by LC-MS/MS analysis | Rattus norvegicus | 1 | ALA4477274 | organism-based format | Scientific Literature | |
10. | ALA4480307 | ADME | AUC (0 to infinity) in Sprague-Dawley rat at 1 mg/kg, iv administered as bolus dose by LC-MS/MS analysis | Rattus norvegicus | 1 | ALA4477274 | organism-based format | Scientific Literature | |
11. | ALA4480308 | ADME | AUC (0 to infinity) in Sprague-Dawley rat at 15 mg/kg, po administered via gastric intubation by LC-MS/MS analysis | Rattus norvegicus | 1 | ALA4477274 | organism-based format | Scientific Literature | |
12. | ALA4480309 | ADME | Cmax in Sprague-Dawley rat at 15 mg/kg, po administered via gastric intubation measured up to 48 hrs by LC-MS/MS analysis | Rattus norvegicus | 1 | ALA4477274 | organism-based format | Scientific Literature | |
13. | ALA4480310 | ADME | Oral bioavailability in Sprague-Dawley rat at 15 mg/kg administered via gastric intubation measured up to 48 hrs by LC-MS/MS analysis | Rattus norvegicus | 1 | ALA4477274 | organism-based format | Scientific Literature | |
14. | ALA4480311 | ADME | Drug level in Sprague-Dawley rat blood at 15 mg/kg, po administered via gastric intubation up to 24 hrs by LC-MS/MS analysis | Rattus norvegicus | 1 | ALA4477274 | organism-based format | Scientific Literature | |
15. | ALA4480312 | ADME | Tmax in Sprague-Dawley rat at 15 mg/kg, po administered via gastric intubation by LC-MS/MS analysis | Rattus norvegicus | 1 | ALA4477274 | organism-based format | Scientific Literature | |
16. | ALA5138233 | Binding | Inhibition of DOT1L (unknown origin) | Homo sapiens | 15 | ALA5136992 | single protein format | Scientific Literature | |
17. | ALA5138236 | Functional | Inhibition of methylation of H3K79 in human MCF-10A cells by fluorescence assay | Homo sapiens | 3 | ALA5136992 | cell-based format | Scientific Literature |